Michael Petusky

Stock Analyst at Barrington Research

(2.14)
# 2,937
Out of 5,246 analysts
246
Total ratings
37.5%
Success rate
-4.36%
Average return

Stocks Rated by Michael Petusky

Orthofix Medical
May 22, 2026
Maintains: Outperform
Price Target: $17$15
Current: $10.75
Upside: +39.53%
Bioventus
May 22, 2026
Maintains: Outperform
Price Target: $14
Current: $9.28
Upside: +50.86%
U.S. Physical Therapy
May 13, 2026
Maintains: Outperform
Price Target: $103$90
Current: $61.96
Upside: +45.26%
Haemonetics
May 12, 2026
Maintains: Outperform
Price Target: $94$89
Current: $65.49
Upside: +35.90%
LeMaitre Vascular
May 6, 2026
Maintains: Outperform
Price Target: $105$120
Current: $97.75
Upside: +22.76%
Option Care Health
May 1, 2026
Maintains: Outperform
Price Target: $42$32
Current: $20.93
Upside: +52.89%
Lifecore Biomedical
Apr 29, 2026
Maintains: Outperform
Price Target: $5.5$6
Current: $4.94
Upside: +21.58%
OPKO Health
Apr 29, 2026
Downgrades: Market Perform
Price Target: n/a
Current: $1.27
Upside: -
Merit Medical Systems
Apr 20, 2026
Maintains: Outperform
Price Target: $109$107
Current: $64.17
Upside: +66.74%
DENTSPLY SIRONA
Mar 2, 2026
Maintains: Outperform
Price Target: $14$17
Current: $10.21
Upside: +66.50%
Maintains: Outperform
Price Target: $16$17
Current: $14.90
Upside: +14.09%
Maintains: Outperform
Price Target: $79$97
Current: $74.21
Upside: +30.71%
Maintains: Outperform
Price Target: $1$1.5
Current: $0.6617
Upside: +126.69%